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Introduction
The co-chaperone murine stress-inducible protein 1 (mSTI1)
is a homologue of the human heat-shock protein 70 (Hsp70) /
heat-shock protein 90 (Hsp90) organizing protein (Hop) and
yeast stress-inducible protein 1 (STI1) (Blatch et al., 1997).
Hop acts as an adaptor protein, mediating the association of
the molecular chaperones Hsp70 and Hsp90 via specific
tetratricopeptide-repeat (TPR)-rich binding domains (Pratt and
Toft, 1997; Scheufler et al., 2000). mSTI1 has been shown to
associate with heat-shock cognate 70 (Hsc70) and Hsp90, and
to localize mainly to the cytoplasm (Lässle et al., 1997; van der
Spuy et al., 2000). However, recent reports have indicated that
mSTI1 can also localize to the cell surface (Zanata et al., 2002)
and to the lysosome surface (Agarraberes and Dice, 2001).
The mouse Hsp70 gene family has seven members.
Cytoplasmic Hsc70, endoplasmic reticulum Grp78 (Bole et al.,
1986) and mitochondrial Hsp70 (Michikawa et al., 1993) are
constitutively expressed; Hsp70-1 (Dingwall et al., 1988) and
Hsp70-3 (Perry et al., 1994) are heat inducible; and Hsp70-2
(Zakeri et al., 1990) and heat-shock cognate t (Hsc70t) (Hang
and Fox, 1995) are developmentally regulated. Hsc70 assists
the folding of client proteins including nascent polypeptides
(Helmbrecht et al., 2000). It also facilitates protein transport
across mitochondrial and nuclear membranes (Okuno et al.,
1993) and is involved in ubiquitin-mediated degradation of
proteins (Bercovich et al., 1997). The diverse functions of
Hsc70 might include a role within the cell cycle, because
Hsc70 expression is coupled by an unknown mechanism to
cell-cycle position in exponentially growing HeLa cells (Hunt
et al., 1999), with Hsc70 mRNA beginning to accumulate in
mid-G1-phase, peaking in late G1-phase and declining during
S-phase. Similarly, mRNA levels are increased in serum-
stimulated CV1 monkey cells (Sainis et al., 1994) and Rat1
cells (Sorger and Pelham, 1987), and protein studies have
indicated that a translocation of Hsc70 into the nucleus occurs
during S-phase (Milarski and Morimoto, 1986). Interestingly,
expression of Hsc/Hsp70 has been shown to not be cell-cycle
regulated (Whitfield et al., 2002).
Several chaperones have been shown to be phosphorylated
by cell cycle kinases: murine Hsp25 and human Hsp27
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The co-chaperone murine stress-inducible protein 1
(mSTI1), an Hsp70/Hsp90 organizing protein (Hop)
homologue, mediates the assembly of the Hsp70/Hsp90
chaperone heterocomplex. The mSTI1 protein can be
phosphorylated in vitro by cell cycle kinases proximal to a
putative nuclear localization signal (NLS), which
substantiated a predicted casein kinase II (CKII)-cdc2
kinase-NLS (CcN) motif at position 180-239 and suggested
that mSTI1 might move between the cytoplasm and the
nucleus under certain cell cycle conditions. The mechanism
responsible for the cellular localization of mSTI1 was
probed using NIH3T3 fibroblasts to investigate the
localization of endogenous mSTI1 and enhanced green
fluorescent protein (EGFP)-tagged mSTI1 mutants.
Localization studies on cell lines stably expressing
NLSmSTI1-EGFP and EGFP demonstrated that the
NLSmSTI1 was able to promote a nuclear localization of
EGFP. The mSTI1 protein was exclusively cytoplasmic in
most cells under normal conditions but was present in the
nucleus of a subpopulation of cells and accumulated in the
nucleus following inhibition of nuclear export (leptomycin
B treatment). G1/S-phase arrest (using hydroxyurea)
and inhibition of cdc2 kinase (using olomoucine) but
not inhibition of casein kinase II (using 5,6-
dichlorobenzimidazole riboside), increased the proportion
of cells with endogenous mSTI1 nuclear staining. mSTI1-
EGFP behaved identically to endogenous mSTI1. The
functional importance of key residues was tested using
modified mSTI1-EGFP proteins. Inactivation and
phosphorylation mimicking of potential phosphorylation
sites in mSTI1 altered the nuclear translocation.
Mimicking of phosphorylation at the mSTI1 CKII
phosphorylation site (S189E) promoted nuclear
localization of mSTI1-EGFP. Mimicking phosphorylation
at the cdc2 kinase phosphorylation site (T198E) promoted
cytoplasmic localization of mSTI1-EGFP at the G1/S-phase
transition,whereas removal of this site (T198A) promoted
the nuclear localization of mSTI1-EGFP under the same
conditions. These data provide the first evidence of nuclear
import and export of a major Hsp70/Hsp90 co-chaperone
and the regulation of this nuclear-cytoplasmic shuttling by
cell cycle status and cell cycle kinases.
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are phosphorylated by MAPK-activated protein kinase 2
(MAPKAP kinase 2) (Stokoe et al., 1992), heat-shock
transcription factor 1 (HSF1) by cell division cycle 2 (cdc2)
kinase (Reindl et al., 1997) and Hsp90 (Lees-Miller and
Anderson, 1989), calnexin (Ou et al., 1992) and the
immunosuppressant FK506-binding protein 52 (FKBP52)
(Miyata et al., 1997) by casein kinase II (CKII). The mSTI1
protein has been shown to be phosphorylated in vitro by cell
cycle kinases, CKII and cdc2 kinase, at residues proximal to a
putative nuclear localization signal (NLS), substantiating a
predicted CKII-cdc2-NLS (CcN) motif (Longshaw et al.,
2000). CKII is important in the transition of cells from the G0
phase to the G1 phase of the cell cycle, and for continuing
passage through the early G1 phase (Pyerin, 1994). The
mammalian cdc2 kinase, when complexed with cyclin B,
shows high similarity to the invertebrate M-phase-promoting
factor (MPF), which initiates mitosis (Matsumoto and
Fujimoto, 1990). A range of proteins, including p53 (Bischoff
et al., 1990), lamin (Loewinger and McKeon, 1988),
nucleoplasmin (Robbins et al., 1991) and the early G1
transcription factor Swi5 (Jans et al., 1995), exhibit similar
CcN motifs. The SV40 T-antigen CcN motif functions under
dual regulation, with phosphorylation at the CKII site
increasing the rate of NLS-dependent nuclear import (Jans and
Jans, 1994) and phosphorylation at the cdc2 kinase site
inhibiting transport and markedly reducing the level of
maximal nuclear accumulation (Jans et al., 1991). The
inhibition by cdc2 kinase phosphorylation is thought to be
through cytoplasmic retention or NLS masking, whereas
the CKII phosphorylation-mediated enhancement might act
through an increased affinity of association with the
karyopherin complex, enhancing the docking rate at the
nuclear pore complex (NPC) (Jans and Jans, 1994).
There is evidence for the existence of in vivo phosphorylated
forms of mSTI1 and its homologues, Hop and STI1. The
isoform compositions of Hop and mSTI1 shifted to more acidic
forms after viral transformation and heat stress, respectively
(Honore et al., 1992; Lässle et al., 1997), suggesting the stress-
induced phosphorylation of a Hop/mSTI1 population. In
addition, the major acidic variants of Hop have been shown to
be phosphorylated (Honore et al., 1992). An acidic isoform of
yeast STI1 has also been demonstrated, suggesting post-
translational phosphorylation of STI1 (Nicolet and Craig,
1989).
The in vitro phosphorylation of mSTI1 in the vicinity of the
proposed NLS by cell cycle kinases suggested a cell-cycle-
dependent regulation of the nuclear localization of mSTI1
(Longshaw et al., 2000). Furthermore, the cytoplasmic
localization of mSTI1 (Lässle et al., 1997) highlighted the
proposed CcN motif as a potentially important regulator of
mSTI1 localization, with relevance for the function of the
Hsp70-mSTI1-Hsp90 multichaperone machine. Here, we
provide evidence for a functional NLS within mSTI1 and the
regulation of mSTI1 nuclear localization by the cell cycle and
cell cycle kinases.
Materials and Methods
General procedures
Common procedures such as polymerase chain reaction (PCR),
ligation reactions, agarose gel electrophoresis, competent bacterial
cell preparation, plasmid DNA isolation and restriction enzyme
digestion were performed according to standard protocols (Sambrook
and Russell, 2001). Sodium-dodecyl-sulfate/polyacrylamide gel
electrophoresis (SDS-PAGE) was according to Laemmli (Laemmli,
1970) and western blotting according to Towbin et al. (Towbin et al.,
1979). Luminol-based chemiluminescence detection reagents (ECL;
Amersham Pharmacia Biotech) were used for immunodetection.
Plasmid construction
The mammalian construct pB-mSTI1-EGFP encodes full-length
mSTI1 as an N-terminal fusion with enhanced green fluorescent
protein (EGFP). mSTI1 cDNA was PCR amplified from template
pGEX3X2000 (Lässle et al., 1997) (Expand High Fidelity PCR
system; Roche) to introduce a Kozak sequence and remove the stop
codon. The PCR product was subcloned into pGEM(T) Easy Vector
System I (Promega), the mSTI1 fragment subcloned into pCineoEGFP
NheI/SacII sites, the mSTI1-EGFP fragment subcloned into pSK
NheI/NotI sites and finally into pBCMGSNeo (Karasuyama and
Melchers, 1988) XhoI/NotI sites to produce pB-mSTI1-EGFP. pB-
NLSmSTI1-EGFP encodes the mSTI1 amino acid sequence 222-239
(which contains the potential bipartite NLS) as an N-terminal fusion
with EGFP. EGFP cDNA was PCR amplified from the template
pCineoEGFP with a primer encoding mSTI1 amino acids 222-239 and
a Kozak sequence. The resulting PCR product was subcloned into
pGEM(T) and the NLSmSTI1-EGFP fragment cloned into the
pBCMGSNeo XhoI/NotI sites to produce pB-NLSmSTI1-EGFP. The
pET5a2000 bacterial construct encodes full-length mSTI1 for
heterologous expression in Escherichia coli. mSTI1 cDNA was PCR
amplified from the template pGEX3X2000, the PCR product
subcloned into pGEM(T) and the mSTI1 fragment cloned into pET5a
(Stratagene) NdeI/NheI sites to produce pET5a2000.
Site-directed mutagenesis
pB-mSTI1(S189A)-EGFP and pB-mSTI1(T198A)-EGFP were
generated to encode full-length mSTI1 as an N-terminal fusion
with EGFP, with alanine substitutions at positions 189 and 198,
respectively. Similarly pB-mSTI1(S189E)-EGFP and pB-
mSTI1(T198E)-EGFP included glutamic acid substitutions at
positions 189 and 198, respectively. Site-directed mutagenesis
reactions were carried out using the template pSK-mSTI1-EGFP in a
linear amplification reaction (Quikchange Site-directed Mutagenesis
kit; Stratagene). Mutated mSTI1-EGFP cDNA fragments were cloned
into pBCMGSNeo XhoI/NotI sites. Plasmid construct pET5a2000
was used as a template to produce mSTI1(T198A) and
mSTI1(T198A,T332A) expressing derivative plasmids
(pET5a2000T198A and pET5a2000T198A-T332A) in a similar linear
amplification reaction.
Transfections
Mouse NIH3T3 fibroblasts were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% calf serum, penicillin (100
U ml–1) and streptomycin (100 U ml–1) (complete media; Highveld
Biological) in a humidified atmosphere, at 37°C with 10% CO2. For
episomally stable transfectants, NIH3T3 fibroblasts were seeded to
30-50% confluence, transfected by the calcium phosphate method and
selected with geneticin (0.5 mg ml–1) (Gibco-BRL). Transient
transfections were carried out using Lipofectamine Plus (Gibco-BRL)
according to the manufacturer’s instructions. Cells were fixed in 3.7%
formaldehyde for 10 minutes and nuclei stained with 2 m g ml–1 4¢ , 6-
diamidino-2-phenylindole (DAPI; Sigma) in PBS. Slides were
mounted in fluorescent mounting solution (DAKO) and the
fluorescence visualized with a Zeiss LSM 510 laser scanning confocal
microscope. Quantitation of cells showing a particular localization
pattern was determined for all the cell treatments by assessment of
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approximately 100 cells in each of five separate fields by an observer
who was blind to the experimental status.
Indirect immunofluorescence
24 hours after transient transfection, cells were fixed in 3.7%
formaldehyde. After fixation, all incubation and wash buffers
contained 0.1% saponin (Sigma) for permeabilization. To reduce non-
specific cross-reactivity, cells were incubated in blocking buffer [3%
bovine serum albumin (BSA), 10% normal donkey serum in PBS] for
30 minutes before incubation with rabbit anti-mSTI1 antibody SF1
(Lässle et al., 1997) 1:250 in blocking buffer. Secondary antibody
incubations were performed with Cy3-conjugated donkey anti-rabbit
antibody (Pierce) diluted 1:200 in blocking buffer, and nuclei were
stained with DAPI. Slides were mounted in fluorescent mounting
solution (DAKO) and the fluorescence visualized with a Zeiss LSM
510 laser scanning confocal microscope. The following excitation and
emission conditions were used in separate channels with either a 40·
or 63· oil-immersion objective: DAPI, 364 nm and 475-525 nm;
FITC/GFP, 488 nm and 505-530 nm; Cy3, 543 nm and 560 nm. Cells
showing a particular localization pattern were quantified for all the cell
treatments by assessing approximately 100 cells in each of five
separate fields by an observer who was blind to the experimental status.
Treatment of cells with kinase inhibitors and cell cycle
inhibitors
NIH3T3 cells stably expressing mSTI1-EGFP, mSTI1(S189A)-EGFP,
mSTI1(S189E)-EGFP, mSTI1(T198A)-EGFP and mSTI1(T198E)-
EGFP were treated with cell-cycle inhibitors 24 hours after seeding.
CKII was inhibited by incubating the cells with 0.3 mM 5,6-
dichlorobenzimidazole riboside (DRB) and cdc2 kinase was inhibited
by incubation with 0.3 mM olomoucine for 8 hours. Nuclear export
was inhibited by the addition of 18.5 nM leptomycin B for 3 hours.
Cells were arrested in G1/S phase by the addition of 10 mM
hydroxyurea for 10 hours. No initial arrest in G0/G1 by the incubation
of cells in serum-free media was performed because this would result
in a stressed cellular state. Cells were fixed and proteins were
visualized as before.
Immunoprecipitation of GFP-mSTI1 and its derivates
Cells were transfected with pB-mSTI1-EGFP, pB-mSTI1(S189A)-
EGFP, pB-mSTI1(T198A)-EGFP, pB-mSTI1(S189E)-EGFP, pB-
mSTI1(T198E)-EGFP or pB-EGFP. 24 hours after transfection, cells
were washed twice in PBS and scraped into 500 m l modified RIPA
buffer (50 mM Tris-HCl pH 7.4, 1% NP40, 0.25% sodium
deoxycholate, 50 mM NaCl) containing a cocktail of protease
inhibitors (Sigma). Following 30 minutes incubation at 4°C, cell
lysates were centrifuged at 17,500 g for 15 minutes. The supernatant
was incubated overnight at 4°C with the monoclonal anti-GFP
antibody 3E6 (Molecular Probes) or with non-immune IgG. Before
incubation, antibodies were immobilized to protein-G/Sepharose
(Amersham Pharmacia Biotech) using the cross-linker DSS (Pierce)
according to the manufacturers instructions. After the overnight
incubation the protein-G/Sepharose was washed six times for 10
minutes each in modified RIPA buffer. After washing, bound proteins
were eluted with ImmunoPure elution buffer (Pierce) and subjected
to western-blot analyses. Immunoprecipitated mSTI1-EGFP and
mSTI1 were detected with a polyclonal antibody raised against GST-
mSTI1 at 1:1000 (Lässle et al., 1997). Co-immunoprecipitated Hsc70
and Hsp70 were detected with BRM-22 (Sigma) at 1:1000, and Hsp90
was detected with sc31119 at 1:500 (Santa Cruz Biotechnology).
Purification and phosphorylation of mSTI1 proteins
Soluble cell extract were prepared from induced cultures of E. coli
BL21(DE3)[pET5a2000], E. coli BL21(DE3)[pET5a2000T198A] and
E. coli BL21(DE3)[pET5a2000T198A-T332A] expressing mSTI1,
mSTI1(T198A) and mSTI1(T198A,T332A), respectively. The cell
extracts were loaded onto a 30 ml Polybuffer Exchanger PBE column
(Amersham Pharmacia Biotech) pre-equilibrated in start buffer (20
mM Tris-HCl, pH 8.0). 1.5 ml fractions were collected at a flow rate
of 30 ml hr–1. The column was washed with start buffer (50 ml), wash
buffer (50 ml; start buffer containing 0.1 M NaCl) and an elution
gradient of 0.1-0.3 M NaCl in wash buffer (50 ml). All fractions were
tested for the presence and purity of mSTI1 using western-blot analysis
and SDS-PAGE. Cdc2 kinase assays were performed on purified
mSTI1 according to Longshaw et al. (Longshaw et al., 2000), except
that the assays were incubated for 3 hours and 9 hours.
Results
mSTI1 is predominantly cytoplasmic
We found, as shown previously (Lässle et al., 1997), that
mSTI1 was predominantly localized to the cytoplasm (Fig. 1A,
middle). To determine the subcellular localization of mSTI1 in
a system that could be subsequently engineered to produce
modified mSTI1 proteins, a fusion of mSTI1 with EGFP at its
C-terminus (mSTI1-EGFP) was constructed. NIH3T3 mouse
fibroblast cells stably expressing mSTI1-EGFP and EGFP
were analysed by confocal laser fluorescence microscopy.
mSTI1-EGFP was localized to the cytoplasm of most cells,
whereas EGFP was found to localize to the nucleus and
cytoplasm of all cells (Fig. 1B). In addition, exogenously
expressed mSTI1-EGFP was found to co-localize with
endogenous mSTI1 (Fig. 1A). This suggested that the fusion
of EGFP to the C-terminus of mSTI1 had no significant effect
on its subcellular distribution.
Amino acids 222-239 functioned as an NLS
Proteins larger than 40-60 kDa cannot enter the nucleus
through the nuclear pore complex by passive diffusion (Okuno
et al., 1993). Because mSTI1-EGFP (at 89 kDa) is too large
and endogenous mSTI1 (at 63 kDa) is of borderline mass to
diffuse into the nucleus, a functional nuclear localization
signal (NLS) would be required for the active transport of
mSTI1 into the nucleus. Yet we observed that endogenous
mSTI1 and mSTI1-EGFP were present in the nucleus of 10-
20% of the cells (e.g. Fig. 2B). To assess the potential of the
proposed mSTI1 NLS to direct nuclear import, a construct
encoding amino acids 222-239 fused to the N-terminus of
EGFP was expressed in NIH3T3 cells. The expressed protein,
denoted NLSmSTI1-EGFP, localized strongly to the nucleus in
all cells compared with the EGFP control, which was localized
diffusely throughout the cytoplasm and nucleus in all cells
(Fig. 1B). According to the theoretical size of NLSmSTI1-
EGFP (~30 kDa), one would expect that it could move freely
between the nucleus and the cytoplasm by diffusion. Only a
small proportion of the NLSmSTI1-EGFP was observed in the
cytoplasm, however, suggesting a constitutively active nuclear
import process. These data therefore clearly suggested that
amino acids 222-239 of mSTI1 contain a functional NLS.
Leptomycin B treatment induced nuclear accumulation
of endogenous mSTI1
Although mSTI1 potentially has a functional NLS at positions
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222-239, it remains predominantly cytoplasmic under normal
growth conditions (Figs 1, 2). This might be caused by the
presence of a nuclear export system that predominates over
nuclear import. To assess the potential nuclear export of
mSTI1, NIH3T3 fibroblasts were treated with leptomycin B.
Treatment with leptomycin B for 3 hours induced nuclear
accumulation of endogenous mSTI1 in most cells (Fig. 2A,B).
Similarly, in NIH3T3 stable transfectants expressing mSTI1-
EGFP, treatment with leptomycin B induced nuclear
accumulation of the fusion protein in most cells (Fig. 2A,B).
These data demonstrated that mSTI1 was exported from the
nucleus by a mechanism involving either a functional cis-
acting, leptomycin-B-sensitive nuclear export signal (NES) or
via a NES-containing interaction partner of mSTI1. The
predominant cytoplasmic distribution of mSTI1 under normal
conditions might therefore result from a dynamic equilibrium
between nuclear import and export, in which the rate of export
was higher in most cells.
Kinase inhibition affected the distribution of endogenous
mSTI1
We have previously suggested that the CcN motif of mSTI1
might direct nuclear import under cell cycle control (Longshaw
et al., 2000). The proposed CcN motif would comprise the
NLS at position 222-239 together with the CKII (S189) and
cdc2 kinase (T198) phosphorylation sites located upstream
from the NLS and recognized in vitro. To assess any effect of
specific inhibition of cdc2 kinase and CKII in cells on the
cytoplasmic distribution of mSTI1, we exposed NIH3T3
fibroblasts to olomoucine (a specific inhibitor of cdc2 kinase)
and DRB (a specific inhibitor of CKII). The incidence of cells
with a cytoplasmic distribution of mSTI1 and mSTI1-EGFP
was unchanged after DRB treatment, suggesting that
inactivation of CKII did not change the distribution of mSTI1
(Fig. 2A,B). By contrast, olomoucine treatment resulted in a
marked increase in the incidence of nuclear localization of
mSTI1 (Fig. 2A,B). Similarly, treatment with olomoucine
increased the incidence of nuclear localization of mSTI1-
EGFP in NIH3T3 stable transfectants (Fig. 2A,B). These data
suggested that active cdc2 kinase was required for the
cytoplasmic accumulation of mSTI1.
Arrest at the G1/S-phase transition promoted a nuclear
localization of endogenous mSTI1
We have previously identified a cdc2 kinase phosphorylation
site in mSTI1 that was recognized in vitro (Longshaw et al.,
2000) and, here, we have shown that the inhibition of cdc2
kinase led to an increase in the incidence of nuclear
localization of mSTI1. We speculated that arrest of the
cell at the G1/S-phase transition when cdc2 kinase was
inactive might affect the localization of mSTI1. After
hydroxyurea treatment, there was a marked increase in the
incidence of nuclear localization of mSTI1 (Fig. 3A,B).
Similarly, treatment with hydroxyurea increased the
incidence of nuclear localization of exogenously expressed
mSTI1-EGFP (Fig. 3A,B). These data again suggest that
active cdc2 kinase was required for the cytoplasmic
accumulation of mSTI1 and that the nuclear localization of
mSTI1 was increased when the cells were in the G1/S-phase
stage of the cell cycle.
Mimicking CKII S189 phosphorylation promoted nuclear
localization of mSTI1-EGFP
Exogenously expressed mSTI1-EGFP showed the same
localization characteristics as endogenous mSTI1, so we used
modified derivatives of mSTI1-EGFP to investigate the
mechanism of cytoplasmic-nuclear shuttling of mSTI1. To
assess the effect of removal of the potential CKII
phosphorylation site on mSTI1 localization, S189 was
replaced with an alanine (S189A). The proportion of cells
that demonstrated nuclear localization of expressed protein
was found to be similar in cells expressing mSTI1(S189A)-
EGFP (18%) and mSTI1-EGFP (13%) under normal
conditions (Fig. 4A,B). Studies of the CcN motif in SV40
T-antigen have simulated phosphorylation by replacing
the serine phosphorylation site with a negatively charged
amino acid; this results in an enhancement of nuclear
transport of the SV40 T-antigen (Jans and Jans, 1994).
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Fig. 1. The subcellular localization of mSTI1-EGFP and NLSmSTI1-
EGFP. (A) NIH3T3 fibroblasts were transiently transfected with pB-
mSTI1-EGFP, fixed in 3.7% paraformaldehyde, permeabilized in
0.1% saponin (all panels) and immunostained with SF1 polyclonal
rabbit anti-mSTI1 and Cy3-conjugated donkey anti-rabbit antibodies
(middle and right panel). Cells were mounted and visualized by
confocal laser fluorescence microscopy. Scale bars, 10 m m.
(B) NIH3T3 fibroblasts were stably transfected with pB-EGFP (top),
pB-mSTI1-EGFP (middle) and pB-NLSmSTI1-EGFP (bottom). Cells
were fixed in 3.7% paraformaldehyde and stained with DAPI before
visualization by confocal laser fluorescence microscopy. Scale bars,
10 m m.
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Therefore, to assess the effect of phosphorylation at the CKII
site on nuclear import of mSTI1-EGFP, the serine at position
189 was replaced with a glutamic acid (S189E). The
proportion of cells that demonstrated increased nuclear
localization of expressed protein was found to be greater
in cells expressing mSTI1(S189E)-EGFP (44%) than in
those expressing mSTI1-EGFP (13%) (Fig. 4A,B). This
suggested an enhancing effect of a negative charge at the
S189 site on mSTI1-EGFP nuclear import under normal
conditions.
Fig. 2. The nuclear localization of
mSTI1-EGFP is enhanced by
inhibition of nuclear export and
inhibition of cdc2 kinase but not by
inhibition of CKII. (A) Untransfected
NIH3T3 fibroblasts (left), NIH3T3
fibroblasts stably transfected with pB-
EGFP (middle) or with pB-mSTI1-
EGFP (right) were exposed to
leptomycin B (18.5 nM), olomoucine
(0.1 mM) or DRB (0.3 mM) for 3
hours, 8 hours and 8 hours,
respectively. Untransfected cells were
immunostained to detect endogenous
mSTI1 with SF1 polyclonal rabbit
anti-mSTI1 and Cy3-conjugated
donkey anti-rabbit antibodies, and
transfected cells were fixed in 3.7%
paraformaldehyde before mounting
and visualization by confocal laser
fluorescence microscopy. Scale bars,
10 m m. (B) Cells as above were
exposed to leptomycin B, olomoucine
and DRB, and cells demonstrating
cytoplasmic fluorescence or nuclear
and cytoplasmic fluorescence were
quantified. The error bars represent
standard deviations.
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Mimicking cdc2 kinase T198 phosphorylation promoted
cytoplasmic localization of mSTI1-EGFP
To assess the effect of phosphorylation at the cdc2 kinase
phosphorylation site on nuclear import of mSTI1, the threonine
at position 198 was replaced with glutamic acid (T198E).
Under normal growth conditions, mSTI1-EGFP and
mSTI1(T198E)-EGFP were cytoplasmic in most cells (Fig.
4A,B). Following hydroxyurea treatment, however, the number
of cells with nuclear localization of mSTI1-EGFP was found
to be lower in cells expressing mSTI1(T198E)-EGFP (51%)
than in those expressing mSTI1-EGFP (81%) (Fig. 5A,B). This
suggested an inhibitory effect of a negative charge at the T198
site on mSTI1-EGFP nuclear import under G1/S-phase arrest.
Alternatively, this negative charge might promote cytoplasmic
retention of mSTI1-EGFP under G1/S-phase arrest.
Removal of the cdc2 kinase phosphorylation site
promoted nuclear localization of mSTI1-EGFP
Specific inhibition of cdc2 kinase increased the nuclear
localization of mSTI1, so we assessed the importance of the
potential in vivo cdc2 kinase phosphorylation site T198 by
replacing it with an alanine residue (T198A). The proportion of
cells demonstrating cytoplasmic and nuclear localization of
fluorescence was found to be similar in cells expressing
mSTI1(T198A)-EGFP (11%) to cells expressing mSTI1-EGFP
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Fig. 3. The nuclear localization of endogenous
mSTI1 and mSTI1-EGFP is enhanced by G1/S-
phase arrest. (A) Untransfected NIH3T3
fibroblasts (left), NIH3T3 fibroblasts stably
transfected with pB-EGFP (middle) or with pB-
mSTI1-EGFP (right) were exposed to
hydroxyurea (10 mM) for 10 hours. Untransfected
cells were immunostained to detect endogenous
mSTI1 with SF1 polyclonal rabbit anti-mSTI1
and Cy3-conjugated donkey anti-rabbit
antibodies, and transfected cells were fixed in
3.7% paraformaldehyde before mounting and
visualization by confocal laser fluorescence
microscopy. Scale bars, 10 m m. (B) Cells were
exposed to hydroxyurea as above, and cells
demonstrating cytoplasmic fluorescence or
nuclear and cytoplasmic fluorescence were
quantified. The bars represent standard deviations.
Fig. 4. Phosphorylation mimic at S189 and not T198 affects the
localization of mSTI1-EGFP. (A) NIH3T3 fibroblasts were stably
transfected with pB-mSTI1-EGFP or derivative plasmids pB-
mSTI1(S189A)-EGFP, pB-mSTI1(T198A)-EGFP, pB-
mSTI1(S189E)-EGFP and pB-mSTI1(T198E)-EGFP. Cells were
fixed in 3.7% paraformaldehyde before mounting and visualization
by confocal laser fluorescence microscopy. Scale bars, 10 m m.
(B) Cells were transfected as above, and cells demonstrating
cytoplasmic fluorescence or nuclear and cytoplasmic fluorescence
were quantified. The error bars represent standard deviations.
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(13%) under normal conditions (Fig. 4A,B). By contrast,
although similar proportions of cells expressing mSTI1-EGFP
and mSTI1(T198A)-EGFP showed cytoplasmic and nuclear
localization of expressed protein, a greater nuclear
accumulation of mSTI1(T198A)-EGFP was observed after
hydroxyurea treatment (Fig. 5A,B). The removal of this cdc2
kinase phosphorylation site therefore promoted nuclear
localization of mSTI1-EGFP under G1/S-phase arrest
conditions. These results further confirm the data using the cdc2
inhibitor.
mSTI1-EGFP and its modified derivatives interacted with
mSTI1, Hsp70 and Hsp90
Previously we showed that fusion of mSTI1 to GST and the
amino acid substitutions S189A and T198A did not affect the
functional interaction of mSTI1 with heat-shock proteins
(Lässle et al., 1997; Longshaw et al., 2000). Using anti-GFP
antibodies, we immunoprecipitated mSTI1-EGFP and its
modified derivatives from lysates of transfected NIH3T3 cells.
All the mSTI1-EGFP fusion proteins were found to be
associated with Hsp70 and Hsp90 (Fig. 6). Hsp70 and Hsp90
could not be detected in immunoprecipitates from mock-
transfected or EGFP-expressing cells. In addition, Hsp70 and
Hsp90 were not detected in
immunoprecipitations when
using antibodies not specific for
GFP. Taken together, these data
suggested that mSTI1-EGFP and
all its derivatives used in this
study are functionally equivalent
with respect to their interactions
with Hsp70 and Hsp90.
Interestingly, endogenous
mSTI1 was detected in the immunoprecipitated
complexes with mSTI1-EGFP, suggesting that either
(i) oligomeric forms (possibly dimers) of mSTI1 exist
in vivo, resulting in mSTI1/mSTI1-EGFP hetero-
oligomers when exogenous mSTI1-EGFP is present, or
(ii) more than one subunit of mSTI1 can separately
bind within these chaperone complexes resulting in complexes
that contain endogenous mSTI1 and exogenous mSTI1-EGFP.
Threonine 198 was the major but not the only site
phosphorylated in vitro by cdc2 kinase
Previously, we reported the in vitro phosphorylation of mSTI1
by cdc2 kinase at T198 using recombinant tagged mSTI1
protein in cdc2 kinase assays (Longshaw et al., 2000). To test
the possible existence of cdc2 kinase phosphorylation sites
other than T198, we used untagged recombinant mSTI1 and
mSTI1(T198A) in cdc2 kinase assays, and incubated for 3
hours and 9 hours to enhance any low levels of phosphorylation
at sites other than T198. These longer incubations detected a
low level of phosphorylation in the mSTI1(T198A) reaction
that was above that detected for the autophosphorylation
control (Fig. 7). Therefore, cdc2 kinase was phosphorylating
another site, which we speculated to be T332, the only other
site in mSTI1 that conforms to the cdc2 kinase consensus
sequence. This region resembles another putative CcN motif
(amino acids 326-351) with a putative CKII site at position
S326, a putative cdc2 kinase site at position T332 and a
putative bipartite NLS at positions 337-351. Removal of the
T332 site was performed to produce mSTI1(T198A,T332A).
Fig. 5. Phosphorylation mimic and
phosphorylation site removal at
T198 affects the localization of
mSTI1-EGFP under G1/S-phase
arrest. (A) NIH3T3 fibroblasts were
stably transfected with pB-mSTI1-
EGFP, derivative plasmids pB-
mSTI1(T198E)-EGFP or with pB-
mSTI1(T198A)-EGFP. Cells were
treated with hydroxyurea (10 mM)
for 10 hours and fixed in 3.7%
paraformaldehyde before mounting
and visualization by confocal laser
fluorescence microscopy. Scale
bars, 10 m m. (B) Cells were
transfected as above, and cells
demonstrating cytoplasmic
fluorescence or nuclear and
cytoplasmic fluorescence were
quantified. The error bars represent
standard deviations.
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A lower level of phosphorylation was observed for the double
mutant, suggesting that T332 might also be phosphorylated by
cdc2 kinase. Some residual phosphorylation was still observed
(Fig. 7), however, indicating that there might be another, as yet
unidentified, cdc2 kinase phosphorylation site in mSTI1 that
did not map to T198 or T332. The presence of multiple in vitro
cdc2 kinase phosphorylation sites might explain the spectrum
of mSTI1 isoforms observed in vivo (Lässle et al., 1997) (data
not shown), although T198 appears to be the major in vitro
cdc2 kinase site and can influence the cytoplasmic/nuclear
shuttling of the mSTI1.
Discussion
Chaperones and heat-shock proteins are being recognized as
increasingly important in cell signalling events because of their
association with cell cycle components, regulatory proteins and
members of the mitogenic signal cascade (Helmbrecht et al.,
2000). We previously showed that the co-chaperone mSTI1
was phosphorylated in vitro by the cell cycle kinases, cdc2 and
CKII, and that the sites of phosphorylation (T198 and S189,
respectively) were close to a putative NLS (Longshaw et al.,
2000). These data indicated that the cellular function of mSTI1
might be linked to cell cycle events. Here, we have provided
evidence for the first time that mSTI1 has a functional NLS
and that its localization was affected by cdc2 kinase and was
cell-cycle dependent.
The mSTI1-EGFP expression system readily facilitated the
analysis of the effects on localization of defined amino acid
substitutions at the putative cell cycle kinase phosphorylation
sites. Because mSTI1-EGFP and its modified derivatives
were all found in complexes with Hsp70 and Hsp90 by
immunoprecipitation, the effects of the amino acid
substitutions on localization were unlikely to be the result of
changes in Hsp70-mSTI1 or Hsp90-mSTI1 association.
Interestingly, endogenous mSTI1 was also found in the
immunoprecipitated complexes. We have previously shown
that mSTI1 can exist as a dimer under certain conditions (van
der Spuy et al., 2000; van der Spuy et al., 2001), and others
have shown that yeast STI1 is able to dimerize (Prodromou et
al., 1999). Therefore, for our mSTI1-EGFP studies, there is the
potential that endogenous mSTI1 subunits have oligomerized
with mSTI1-EGFP subunits. Such oligomerization could have
potentially moderated the effects on localization of the amino
acid substitutions (S189A, S189E, T198A and T198E).
Nevertheless, changes in localization were detected using
modified derivatives of mSTI1-EGFP allowing us to probe the
mechanism of mSTI1 nuclear-cytoplasmic shuttling.
To test the functionality of the potential NLS of mSTI1,
mouse NIH3T3 cells were transfected with constructs that
expressed EGFP and NLSmSTI1-EGFP. There was a high
incidence of nuclear accumulation of NLSmSTI1-EGFP relative
to the distribution of EGFP that was both cytoplasmic and
nuclear. This suggested that the putative NLS of mSTI1 was
functional and that mSTI1 might accumulate in the nucleus
under certain conditions. Interestingly, endogenous mSTI1 and
exogenously expressed mSTI1-EGFP were found to accumulate
in the nucleus when nuclear export was inhibited with
leptomycin B. Therefore, we propose that the subcellular
distribution of mSTI1 is a dynamic balance of nuclear import
and export processes, the fulcrum of which might be shifted
under different conditions. The formal demonstration of the
functionality of the putative NLS would require mutagenesis of
the NLS to produce mutant versions that are capable of
associating with Hsp70 and Hsp90 but are disrupted with respect
to nuclear localization. We are currently conducting studies such
as these to comprehensively map the boundaries of the NLS.
It is interesting to note that the Hsp90-binding TPR domain
of mSTI1 (TPR2A) overlaps with the predicted NLS. Based on
the structure of the TPR2A domain of Hop in complex with
the Hsp90 C-terminal MEEVD peptide (Scheufler et al., 2000),
the conserved residues K229 and N233 make contact with the
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Fig. 7. mSTI1 is phosphorylated in vitro at multiple sites by cdc2
kinase. In vitro cdc2 kinase assays were incubated for 3 hours and 9
hours using purified recombinant mSTI1 and its modified derivatives
(5 m M). The phosphorylated proteins were resolved by SDS-PAGE
and the radioactive phosphorylation in the dried gel was detected by
autoradiography.
Fig. 6. mSTI1-EGFP and its modified derivatives can interact
with mSTI1, Hsp70 and Hsp90. Cells were transfected with pB-
mSTI1-EGFP or derivative plasmids pB-mSTI1(S189A)-EGFP,
pB-mSTI1(T198A)-EGFP, pB-mSTI1(S189E)-EGFP, pB-
mSTI1(T198E)-EGFP or pB-EGFP. EGFP chimeric proteins were
immunoprecipitated from transfected and control untransfected
cell lysates with antibodies against GFP (anti-GFP) or non-
immune IgG (IgG) and subjected to western blotting, as indicated.
The mSTI1-EGFP and mSTI1 proteins were detected with a
polyclonal antibody raised against GST-mSTI1 (Lässle et al.,
1997). Hsp90 was detected with monoclonal antibody sc31119
and Hsc70 and Hsp70 were detected with monoclonal antibody
BRM-22. The mSTI1, Hsp90 and Hsp70 proteins all specifically
immunoprecipitated with the mSTI1-EGFP chimeric proteins.
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terminal aspartic acid residue (D0) of the peptide. Furthermore,
Y236 makes contact with E–3 and M–4 of the Hsp90 peptide.
K229, N233 and Y236 are located within the mSTI1 NLS
spacer region. Hsp90 and karyopherin- a are relatively large
proteins (180 kDa and 58 kDa, respectively), and it is therefore
proposed that mSTI1 might be sterically restricted from
simultaneously binding Hsp90 and karyopherin- a , owing to
the close proximity of their respective binding sites. This
alternate binding of Hsp90 or karyopherin- a might have
mechanistic implications for the formation of the Hsp70-
mSTI1-Hsp90 chaperone complex and its localization.
Furthermore, conformational changes induced by
phosphorylation at various sites proximal to these overlapping
binding sites might allow preferential binding of either Hsp90
or karyopherin-a . Phosphorylation of sites within the CcN
motif might therefore not only be a level of regulation of the
import kinetics of the NLS, but also of the assembly of the
Hsp70-mSTI1-Hsp90 chaperone complex. We are currently
investigating both of these possibilities.
We conducted a set of experiments to determine whether or
not CKII had a role in the regulation of the localization of
mSTI1. Treatment of cells with DRB did not result in any
significant change in the localization of endogenous mSTI1 or
exogenously expressed mSTI1-EGFP. This suggested that
inactivation of CKII did not change the distribution of mSTI1,
implying that, under normal conditions, CKII was not
important in maintaining the largely cytoplasmic localization
of mSTI1. This conclusion was supported by the finding that
an alanine substitution at the proposed CKII phosphorylation
site (S189) had no effect on the localization of mSTI1. By
contrast, mimicking of phosphorylation by glutamic acid
substitution at the proposed CKII phosphorylation site
promoted a nuclear localization of mSTI1-EGFP. This
suggested an enhancing effect of a negative charge at the S189
site on mSTI1-EGFP nuclear import under normal conditions.
In addition, these data provided indirect evidence that S189
was an in vivo site of phosphorylation and that
phosphorylation at this site enhanced the nuclear
accumulation of mSTI1.
In contrast to CKII, our experiments suggested that cdc2
kinase might regulate mSTI1 localization at the level of
cytoplasmic retention. Endogenous mSTI1 and exogenously
expressed mSTI1-EGFP accumulated in the nucleus when cells
were arrested in G1/S phase and when cdc2 kinase was inactive.
In addition, mSTI1(T198E)-EGFP was found to have a lower
incidence of nuclear accumulation than mSTI1-EGFP under
conditions of G1/S-phase arrest, whereas there was an increased
incidence of nuclear accumulation of mSTI1-EGFP(T198A)
under the same conditions. These amino acid substitution
results suggested that a negative charge at the predicted cdc2
kinase phosphorylation site inhibited nuclear accumulation or,
conversely, promoted cytoplasmic retention. Taken together,
these results suggested that mSTI1 was retained in the
cytoplasm under normal conditions possibly through
phosphorylation at the cdc2 kinase phosphorylation site (T198).
This would mean that any subsequent recruitment of mSTI1 to
the nucleus at G1/S-phase arrest would require the generation
of unphosphorylated or dephosphorylated mSTI1. Therefore,
the mechanism of nuclear translocation might involve: (i)
inactivation of cdc2 kinase, so that increased levels of newly
synthesized unphosphorylated mSTI1 accumulate as a result of
protein turnover; and/or (ii) active dephosphorylation of
existing mSTI1 at the cdc2 kinase phosphorylation site by
activation/upregulation of a specific phosphatase.
The mSTI1 protein might be recruited to the nucleus of
G1/S-phase-arrested cells or during S phase in concert with its
chaperone partners, Hsp70 and Hsp90. Although the co-
chaperone function of mSTI1 within the cytoplasm has been
extensively studied, the role of mSTI1 within the nucleus
remains to be elucidated. We propose that the basic role of
mSTI1 as a co-chaperone for Hsp70 and Hsp90 probably
applies within the nucleus. However, this does not exclude the
possibility that mSTI1 has other specialized activities within
the nucleus. There is evidence that Hsp70 is involved in
chromosomal DNA replication (Milarski and Morimoto, 1986;
Hang and Fox, 1995), and Hsp90 has been implicated in the
activation of telomerase and the replication of chromosome
ends (Forsythe et al., 2001; Grandin and Charbonneau, 2001).
Hsp70 has been shown to translocate to the nucleus during S
phase and during recovery of S phase after stress, suggesting
a role for Hsp70 during activation and/or recovery of DNA
replication (Milarski and Morimoto, 1986; Suzuki and
Watanabe, 1992; Zeise et al., 1998). In addition, it was recently
shown that STI1/Hop and Hsp70 are components of an S-phase
transcription activator complex (Zheng et al., 2003). It remains
to be determined the extent to which mSTI1 is involved in
Hsp70/Hsp90-directed chaperone activities within the nucleus.
Because stresses such as heat shock perturb the cell cycle,
causing arrest at the G1/S and the G1/M transitions (Kühl et
al., 2000), we are currently studying the effects of heat shock
on the localization of mSTI1.
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